Aswin Dereymaker
Controlling the release of indomethacin from glass solutions layered with a rate controlling membrane using fluid-bed processing. Part 1: Surface and cross-sectional chemical analysis
Dereymaker, Aswin; Scurr, David J.; Steer, Elisabeth D.; Roberts, Clive J.; Van den Mooter, Guy
Authors
Dr DAVID SCURR DAVID.SCURR@NOTTINGHAM.AC.UK
PRINCIPAL RESEARCH FELLOW
Elisabeth D. Steer
Professor CLIVE ROBERTS CLIVE.ROBERTS@NOTTINGHAM.AC.UK
HEAD OF SCHOOL
Guy Van den Mooter
Abstract
Fluid bed coating has been shown to be a suitable manufacturing technique to formulate poorly soluble drugs in glass solutions. Layering inert carriers with a drug–polymer mixture enables these beads to be immediately filled into capsules, thus avoiding additional, potentially destabilizing, downstream processing. In this study, fluid bed coating is proposed for the production of controlled release dosage forms of glass solutions by applying a second, rate controlling membrane on top of the glass solution. Adding a second coating layer adds to the physical and chemical complexity of the drug delivery system, so a thorough understanding of the physical structure and phase behavior of the different coating layers is needed. This study aimed to investigate the surface and cross-sectional characteristics (employing scanning electron microscopy (SEM) and time of flight secondary ion mass spectrometry (ToF-SIMS)) of an indomethacin–polyvinylpyrrolidone (PVP) glass solution, top-coated with a release rate controlling membrane consisting of either ethyl cellulose or Eudragit RL. The implications of the addition of a pore former (PVP) and the coating medium (ethanol or water) were also considered. In addition, polymer miscibility and the phase analysis of the underlying glass solution were investigated. Significant differences in surface and cross-sectional topography of the different rate controlling membranes or the way they are applied (solution vs dispersion) were observed. These observations can be linked to the polymer miscibility differences. The presence of PVP was observed in all rate controlling membranes, even if it is not part of the coating solution. This could be attributed to residual powder presence in the coating chamber. The distribution of PVP among the sample surfaces depends on the concentration and the rate controlling polymer used. Differences can again be linked to polymer miscibility. Finally, it was shown that the underlying glass solution layer remains amorphous after coating of the rate controlling membrane, whether formed from an ethanol solution or an aqueous dispersion.
Citation
Dereymaker, A., Scurr, D. J., Steer, E. D., Roberts, C. J., & Van den Mooter, G. (2017). Controlling the release of indomethacin from glass solutions layered with a rate controlling membrane using fluid-bed processing. Part 1: Surface and cross-sectional chemical analysis. Molecular Pharmaceutics, 14(4), 959-973. https://doi.org/10.1021/acs.molpharmaceut.6b01023
Journal Article Type | Article |
---|---|
Acceptance Date | Feb 16, 2017 |
Online Publication Date | Feb 16, 2017 |
Publication Date | Apr 3, 2017 |
Deposit Date | Mar 14, 2017 |
Publicly Available Date | Mar 14, 2017 |
Journal | Molecular Pharmaceutics |
Print ISSN | 1543-8384 |
Electronic ISSN | 1543-8392 |
Publisher | American Chemical Society |
Peer Reviewed | Peer Reviewed |
Volume | 14 |
Issue | 4 |
Pages | 959-973 |
DOI | https://doi.org/10.1021/acs.molpharmaceut.6b01023 |
Keywords | Controlled release, Fluid bed coating, Modulated differential scanning calorimetry, Solid dispersions, Time-of-flight secondary ion mass spectrometry, X-ray powder diffraction |
Public URL | https://nottingham-repository.worktribe.com/output/845434 |
Publisher URL | http://pubs.acs.org/doi/abs/10.1021/acs.molpharmaceut.6b01023 |
Additional Information | This document is the Accepted Manuscript version of a Published Work that appeared in final form in Molecular Pharmaceutics, copyright c American Chemical Society after peer review and technical editing by the publisher. To access the final edited and published work see http://pubs.acs.org/doi/pdf/10.1021/acs.molpharmaceut.6b01023 |
Contract Date | Mar 14, 2017 |
Files
Molec Therapeutics 2017 CONTROLLING THE RELEASE part1.pdf
(4.1 Mb)
PDF
You might also like
Downloadable Citations
About Repository@Nottingham
Administrator e-mail: discovery-access-systems@nottingham.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2025
Advanced Search